Proteolytic bacteria

Proteolytic bacteria represent a functional category of microorganisms characterized by their ability to produce and secrete extracellular proteases that hydrolyze complex proteins into smaller peptides and amino acids (MicrobeWiki, 2021). This group includes diverse genera such as Bacteroides, Clostridium, and Pseudomonas, which are prevalent in the human gastrointestinal tract and various environmental niches. While they contribute to essential processes like nutrient cycling and protein digestion, their overgrowth or presence in non-commensal sites is associated with significant pathology. For instance, in the oral cavity, proteolytic species like Porphyromonas gingivalis are primary drivers of periodontal disease through the degradation of host connective tissues (NCBI, PMC4278125). In the gut, excessive proteolytic fermentation can lead to the production of potentially toxic metabolites, contributing to inflammation and conditions like inflammatory bowel disease (PubMed, 30360446). Because 'proteolytic bacteria' refers to a broad ecological class rather than a specific molecular entity, it is not considered a single therapeutic target; instead, it is managed through antimicrobial strategies or microbiome-targeted therapies. Therapeutic challenges include the risk of antibiotic resistance and the unintended depletion of beneficial commensal bacteria.

Other names

Proteolytic microorganismsProtein-degrading bacteriaProteolytic microbiota

Antibacterial agents typically inhibit cell wall synthesis, disrupt protein synthesis at the ribosome, or interfere with DNA replication; specific experimental inhibitors like Atuzaginstat target bacterial virulence factors such as gingipains (StatPearls, 2023; NCBI, PMC6354655).